1. Clinical and prognostic features of lymphomas arising in the head and neck region: Our experience of preferential association of different histotypes with various sites of origin in ninety patients. (10th June 2013) Authors: Bussu, F.; Hohaus, S.; Bastanza, G.; Bozzoli, V.; Tisi, M.C.; Martini, M.; Paludetti, G.; Almadori, G. Journal: Clinical otolaryngology Issue: Volume 38:Number 3(2013:Jun.) Page Start: 248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OUTCOMES IN FIRST RELAPSED‐REFRACTORY YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: RESULTS FROM THE MANTLE‐FIRST STUDY. (12th June 2019) Authors: Visco, C.; Di Rocco, A.; Tisi, M.C.; Morello, L.; Evangelista, A.; Zilioli, V.R.; Rusconi, C.; Hohaus, S.; Sciarra, R.; Re, A.; Tecchio, C.; Chiappella, A.; Marin‐Niebla, A.; McCulloch, R.; Gini, G.; Perrone, T.; Nassi, L.; Pennese, E.; Stefani, P.M.; Cox, M.C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Retrospective analysis on R‐DHAP/OX and ASCT as salvage treatment for relapsed/refractory high‐risk follicular lymphoma. (June 2017) Authors: Ghione, P.; Cavallo, F.; Visco, C.; Chen, Z.; Nicolosi, M.; Castellino, A.; Tisi, M.C.; Dogliotti, I.; Boccadoro, M.; Leonard, J.P.; Vitolo, U.; Martin, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rituximab, bendamustine and cytarabine (R‐BAC) in patients with relapsed‐refractory aggressive B‐ and T‐cell lymphoma. (June 2017) Authors: Tisi, M.C.; Paolini, R.; Piazza, F.; Ravelli, E.; Carli, G.; Perbellini, O.; Ruggeri, M.; Visco, C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗